Halozyme Therapeutics reported $12.32M in Selling and Administration Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 96.79M 14.87M
Agios Pharmaceuticals AGIO:US $ 29.22M 4.34M
Alnylam Pharmaceuticals ALNY:US $ 153.82M 1.08M
Amarin AMRN:US 107.2M 1.4M
Amgen AMGN:US $ 1.38B 130M
Aptinyx Inc APTX:US $ 5.07M 94K
Arena Pharmaceuticals ARNA:US $ 31.94M 2.48M
Baxter International BAX:US $ 648M 44M
Cara Therapeutics CARA:US $ 5.65M 683K
Cytokinetics CYTK:US $ 21.2M 5.6M
Eli Lilly And LLY:US $ 1.69B 109.7M
Esperion Therapeutics ESPR:US $ 46.32M 14.75M
Halozyme Therapeutics HALO:US $ 12.32M 1.26M
Immunogen IMGN:US $ 9.73M 481K
Intercept Pharmaceuticals ICPT:US $ 57.65M 1.62M
Intra Cellular Therapies ITCI:US $ 69.85M 17.27M
Intrexon XON:US $ 20M 1.3M
JAZZ PHA JAZZ:US 429.03M 168.52M
Mannkind MNKD:US $ 20.06M 2.64M
Minerva Neurosciences NERV:US $ 3.44M 806.44K
Nektar Therapeutics NKTR:US $ 29.56M 2.12M
Peregrine Pharmaceuticals PPHM:US $ 4.46M 595K
Pfizer PFE:US $ 2.79B 134M
Rigel Pharmaceuticals RIGL:US $ 22.38M 257K
United Therapeutics UTHR:US $ 112.8M 2.9M
Vanda Pharmaceuticals VNDA:US $ 28.35M 1.45M